The exosome research market is valued at an estimated USD 144 million in 2021 and is projected to reach USD 661 million by 2026, at a CAGR of 35.6% during the forecast period, owing to increased funding for life sciences research, the high global prevalence of cancer, and the increasing interest in exosome-based procedures.
By product & service, the kits & reagents segment accounted for the largest share of the exosome research market Based on product and service, the exosomes market is segmented into kits & reagents, instruments, and services.The kits & reagents segment is further divided into antibodies, isolation, purification, quantitation kits & reagents, and other kits & reagents.
Circulating exosomal microRNAs (miRNAs) have emerged as valuable biomarker candidates, making it imperative to characterize these exosomes carefully.This has propelled the use of these entities in exosome research to develop easy-to-use kits and reagents.
Additionally, isolation and purification are critical steps in exosome research protocols, contributing to their large-scale adoption in the market.
Asia Pacific: The fastest-growing region in the exosome research market.
The Asia Pacific exosome research market is registered to grow at the fastest pace during the forecast period. The rising disposable income, infrastructural developments, and penetration of cutting-edge diagnostic technologies in Asian countries such as India and China offer significant growth opportunities for manufacturers and distributors of exosomes.
North America: The North America region accounted for the largest share of the exosome research market North America accounted for the largest share of the exosome research market.The US is the key revenue contributor to the North American exosome research market.
The high prevalence of cancer coupled with the increasing demand for early and effective disease diagnosis and treatment is the key factor driving market growth in the US.
Breakdown of primaries The study contains insights from various industry experts, ranging from component suppliers to Tier 1 companies and OEMs. The break-up of the primaries is as follows: • By Respondent– Supply Side- 40%, Demand Side- 60% • By Designation— Executives- 25%, CXOs & Directors--30%, Managers - 45% • By Region— North America - 40%, Europe - 25%, APAC – 20%, LATAM- 10%, MEA- 5%
Thermo Fisher Scientific (US), QIAGEN N.V. (Netherlands), Bio-Techne (US), System Biosciences, LLC. (US), NX PharmaGen (US), Miltenyi Biotec (Germany), AMS Biotechnology (Europe) Limited (UK), NanoSomiX (US), Lonza (Switzerland), and Norgen Biotek Corp. (Canada) are some of the leading players operating in the global exosome research market.
Research Coverage: The report segments the exosome research market based on region (North America, Europe, Asia Pacific, and Rest of the World), Product & Service (Kits & Reagents (Antibodies, Isolation, Purification, Quantitation Kits & Reagents, Other Kits & Reagents), Instruments, Services), Indication (Cancer (Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer, Other Cancers), Neurodegenerative Diseases, Cardiovascular Diseases, Infectious Diseases, Other Cancers), Application (Biomarkers, Vaccine Development, Tissue Regeneration, and Other Applications), End User (Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Hospitals & Clinical Testing Laboratories). The report also provides a comprehensive review of market drivers, challenges, and opportunities in the exosome research market.
Key Benefits of Buying the Report: The report will help the leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall market and the sub-segments.This report will help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies.
The report also helps stakeholders understand the pulse of the exosome research market and provides them information on key market drivers, challenges, and opportunities.
Our reports have been used by over 10K customers, including:
The global ATP assays market is projected to reach USD 412 million by 2027 from USD 276 million in 2022, at a CAGR of 8.4%. The growth of this market can largely be attributed to the increasing food safety concerns, growing demand for ATP assays in pharmaceutical & biotechnology companies, rising investments in pharmaceutical & biotechnology...
The global terahertz technology market was valued at USD 0.6 billion in 2022 and is projected to reach USD 1.2 billion by 2027, registering a CAGR of 14.7% during the forecast period. The rise in demand for terahertz technology-based products is also attributed to stringent government regulations for public safety and homeland security, the...
248 pages •
By The Business Research Company
• Jun 2022
Research Antibodies And Reagents Global Market Opportunities And Strategies To 2030: COVID-19 Growth And Change provides the strategists; marketers and senior management with the critical information they need to assess the global research antibodies and reagents market as it emerges from the COVID 19 shut down. Description: Where...
The High Potency APIs /HPAPI Market is projected to register a CAGR of 8.5% during the forecast period. During the COVID 19 pandemic, the High Potency APIs /HPAPI Market was adversely affected. COVID 19 primarily affected the supply chain of the API market. Since Southeast Asia (specifically China and India) is the hub for the production...
Wearable Injectors Market By Type (On-Body and Off-Body), Usage (Disposable and Semi-Reusable), Technology (Electronic, Mechanical, and Others), Mechanism Of Injection (Motor Driven, Spring Driven, Expanding Battery, Rotary Pump, Collapsible Reservoir, and Pressurized Gas), Therapeutic Area (Diabetes, Oncology, Cardiovascular Disease,...
The global rehabilitation equipment market is projected to reach USD 19.8 billion by 2027 from USD 14.9 billion in 2022, at a CAGR of 5.9% during the forecast period. Increasing geriatric population and obese populations, increasing chronic diseases, high risk of injuries to caregivers during the manual handling of patients, and increasing...
The global depth of anesthesia monitoring market is projected to reach US$ 280.83 million by 2028 from US$ 203.32 million in 2021; it is expected to grow at a CAGR of 4.7% from 2021 to 2028. The rising number of surgical procedures drives the overall growth of the depth of anesthesia monitoring market. However, the high maintenance cost of...
The human microbiome market is projected to reach USD 1,370 million by 2029 from USD 269 million in 2023, at a CAGR of 31.1% from 2023 to 2029. The major factor driving the growth of the human microbiome market is the increasing focus on human microbiome therapy development. The human microbiome as a validated target for drug development &...
The soft tissue repair market is projected to reach USD 17.2Billion by 2027 from USD 13.6Billion in 2022, at a CAGR of 4.7% during the forecast period. Growth in this market is mainly driven by Increasing aging population and obesity rate, growing incidence of sports injuries, strong focus on R&D leading to the launch of technologically...
Oncology information systems manage data from various treatment schedules, treatment plans, and treatment delivery for each patient.Focus on laying a framework on standardization in OIS is further advancing the level of care for each cancer patient through a multidisciplinary approach. Factors such as increasing adoption of OIS solutions...
Patient Data Management
Medical Technology Density
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.